Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: A 3-year prospective cohort study

Nephrology Dialysis Transplantation

Volumn 28, Issue 3, 2013, Pages 671-682

  Chen, Yue Ren ^a   Yang, Yu ^a,b   Wang, Shu Chuan ^a,c   Chiu, Ping Fang ^a   Chou, Wen Yu ^a   Lin, Ching Yuang ^d   Chang, Jer Ming ^e   Chen, Tzen Wen ^f   Ferng, Shyang Hwa ^g   Lin, Chun Liang ^h  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g CATHAY GENERAL HOSPITAL   (Taiwan)

^h CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chronic kidney disease; Hospitalization; Mortality; Multidisciplinary care; Renal replacement therapy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COLECALCIFEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATE BINDING AGENT; URIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MULTIDISCIPLINARY CARE; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REIMBURSEMENT; RENAL REPLACEMENT THERAPY; TAIWAN;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84874861641     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs469     Document Type: Article

References (51)

1. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
2. Gilbertson DT, Liu J, Xue JL et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 2005; 16: 3736-3741.
3. Erratum appears in J Am Soc Nephrol. 2006 Feb;17 (2):591.
4. Hsu CC, Hwang SJ, Wen CP et al. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis 2006; 48: 727-738.
5. Wen CP, Cheng TY, Tsai MK et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008; 371: 2173-2182.
6. Hwang SJ, Lin MY, Chen HC et al. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan. Nephrol Dial Transplant 2008; 23: 3192-3198.
7. Weiner DE, Tabatabai S, Tighiouart H et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis 2006; 48: 392-401.
8. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
9. Erratum appears in N Engl J Med. 2008;18(4):4.
10. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050-1065.
11. Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663.
12. Gullion CM, Keith DS, Nichols GA et al. Impact of comorbidities on mortality in managed care patients with CKD. Am J Kidney Dis 2006; 48: 212-220.
13. National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
14. Israni RK, Shea JA, Joffe MM et al. Physician characteristics and knowledge of CKD management. Am J Kidney Dis 2009; 54: 238-247.
15. Dogan E, Erkoc R, Sayarlioglu H et al. Effects of late referral to a nephrologist in patients with chronic renal failure. Nephrology 2005; 10: 516-519.
16. Kessler M, Frimat L, Panescu V et al. Impact of nephrology referral on early and midterm outcomes in ESRD: EPidemiologie de l'Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study. Am J Kidney Dis 2003; 42: 474-485.
17. Stack AG. Impact of timing of nephrology referral and pre- ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis 2003; 41: 310-318.
18. Huisman RM. The deadly risk of late referral. Nephrol Dial Transplant 2004; 19: 2175-2180.
19. Devins GM, Mendelssohn DC, Barre PE et al. Predialysis psychoeducational intervention extends survival in CKD: a 20-year follow-up. Am J Kidney Dis 2005; 46: 1088-1098.
20. Mason J, Khunti K, Stone M et al. Educational interventions in kidney disease care: a systematic review of randomized trials. Am J Kidney Dis 2008; 51: 933-951.
21. Smart NA, Titus TT, Smart NA et al. Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med 2011; 124: 1073-1080.e1072.
22. Fayer AA, Nascimento R, Abdulkader RCRM. Early nephrology care provided by the nephrologist alone is not sufficient to mitigate the social and psychological aspects of chronic kidney disease. Clinics (Sao Paulo, Brazil) 2011; 66: 245-250.
23. Hemmelgarn BR, Manns BJ, Zhang J et al. Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol 2007; 18: 993-999.
24. Goldstein M, Yassa T, Dacouris N et al. Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis 2004; 44: 706-714.
25. Wu IW, Wang SY, Hsu KH et al. Multidisciplinary predialysis education decreases the incidence of dialysis and reduces mortality- a controlled cohort study based on the NKF/DOQI guidelines. Nephrol Dial Transplant 2009; 24: 3426-3433.
26. Bayliss EA, Bhardwaja B, Ross C et al. Multidisciplinary team care may slow the rate of decline in renal function. Clin J Am Soc Nephrol 2011; 6: 704-710.
27. Curtis BM, Ravani P, Malberti F et al. The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant 2005; 20: 147-154.
28. Wei SY, Chang YY, Mau LW et al. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs. Nephrology 2010; 15: 108-115.
29. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
30. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993; 46: 1075-1079; discussion 1081-1090
31. Chen SC, Chang JM, Chou MC et al. Slowing renal function decline in chronic kidney disease patients after nephrology referral. Nephrology 2008; 13: 730-736.
32. Philipneri MD, Rocca Rey LA, Schnitzler MA et al. Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol 2008; 12: 41-52.
33. P-Guerin A, Maumus-Robert S, Zin A. Insufficient therapeutic management of hypertensive patients with renal failure in France. Arch Cardiovasc Dis 2008; 101: 705-713.
34. Thilly N, Boini S, Kessler M et al. Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale). Nephrol Dial Transplant 2009; 24: 934-939.
35. Smith DH, Johnson ES, Thorp ML et al. Adherence to K/DOQI bone metabolism guidelines. J Ren Nutr 2009; 19: 334-342.
36. Isakova T, Gutierrez OM, Wolf M. A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease. Kidney Int 2009; 76: 705-716.
37. Isakova T, Xie H, Yang W et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011; 305: 2432-2439.
38. Palmer SC, Hayen A, Macaskill P et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 2011; 305: 1119-1127.
39. Avorn J, Winkelmayer WC, Bohn RL et al. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol 2002; 55: 711-716.
40. Inaguma D, Ando R, Ikeda M et al. Nephrologist care for 12 months or more increases hemodialysis initiation with permanent vascular access. Clin Exp Nephrol 2011; 15: 738-744.
41. Wasse H, Kutner N, Zhang R et al. Association of initial hemodialysis vascular access with patient-reported health status and quality of life. Clin J Am Soc Nephrol 2007; 2: 708-714.
42. Pisoni RL, Arrington CJ, Albert JM et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 2009; 53: 475-491.
43. Perl J, Wald R, McFarlane P et al. Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol 2011; 22: 1113-1121.
44. Marron B, Martinez Ocana JC, Salgueira M et al. Analysis of patient flow into dialysis: role of education in choice of dialysis modality. Perit Dial Int 2005; 25(Suppl. 3): S56-S59.
45. Goovaerts T, Jadoul M, Goffin E. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy. Nephrol Dial Transplant 2005; 20: 1842-1847.
46. Manns BJ, Taub K, Vanderstraeten C et al. The impact of education on chronic kidney disease patients' plans to initiate dialysis with self-care dialysis: a randomized trial. Kidney Int 2005; 68: 1777-1783.
47. Chanouzas D, Ng KP, Fallouh B et al. What influences patient choice of treatment modality at the pre-dialysis stage? Nephrol Dial Transplant 2012; 27: 1542-1547.
48. USRDS. United States Renal Data System: Annual data Report. Bethesda, MD: National Institutes of Health, 2007.
49. Mendelssohn DC, Curtis B, Yeates K et al. Suboptimal initiation of dialysis with and without early referral to a nephrologist. Nephrol Dial Transplant 2011; 26: 2959-2965.
50. Mendelssohn DC, Malmberg C, Hamandi B. An integrated review of "unplanned" dialysis initiation: reframing the terminology to "suboptimal" initiation. BMC Nephrol 2009; 10: 22.
51. Wingard RL, Pupim LB, Krishnan M et al. Early intervention improves mortality and hospitalization rates in incident hemodialysis patients: RightStart program. Clin J Am Soc Nephrol 2007; 2: 1170-1175.